Verici Logo

News

Investor Presentation

January 14, 2022
CEO Sara Barrington and CFO David Anderson will provide a live progress and strategy update presentation
Keep Reading

Progress and strategy update

January 12, 2022
Verici Dx provides the following corporate update for the year ended 31 December 2021.
Keep Reading

Clarava™ and Tuteva™ complete testing requirements for completion of clinical validation study

January 6, 2022
Primary data analysis of two lead products on track for Q1 2022 read-out
Keep Reading

Verici Dx and Illumina demonstrate the clinical utility of Illumina’s newly launched data platforms for analytics

January 5, 2022
Readiness for launch, accelerated by Illumina Connected Analytics, represents an important milestone in the path to commercialization of Verici Dx’s lead products
Keep Reading

American Medical Association grants Verici Dx two CPT® Codes

January 4, 2022
Verici Dx announces it has been granted CPT® Proprietary Laboratory Analyses (“PLA”) codes
Keep Reading

TR-1: Standard form for notification of major holdings

December 17, 2021
Standard form for notification of major holdings
Keep Reading

Launch of Barbara T. Murphy Endowed Lectureship

November 8, 2021
Verici Dx announces the launch of lecture commemorating Verici Dx co-founder and former Board member with American Society of Nephrology supported by Verici Dx Plc, Renalytix plc and in conjunction with the American Society of Transplantation, starting at ASN Kidney Week 2022
Keep Reading

Agreement with The American Society of Transplantation to launch Career Development Research Grant

November 1, 2021
Verici Dx announces an agreement with the American Society of Transplantation to establish a Career Development Research Grant, commemorating Dr. Barbara T. Murphy
Keep Reading

Lorenzo Gallon, MD, Appointed as Chair of Science Advisory Board

September 13, 2021
Verici Dx announces the appointment of Lorenzo Gallon, MD, as Chair of the Company’s Science Advisory Board (SAB).
Keep Reading

Half-year Report

September 13, 2021
Strong progress made with key milestones towards commercialisation met ahead of schedule 
Keep Reading
1 2 3
© 2021 VericiDx

 Privacy Policy | Clinical Trials Privacy Policy | Cookie Policy
en English
en Englishfr Frenchit Italianes Spanish
crossmenu